Use of atypical antipsychotics in the elderly: a clinical review

References

• AarslandDLarsenJPLimNGTandbergEOlanzapine for psychosis in patients with Parkinson’s disease with and without dementiaJ Neuropsychiatry Clin Neurosci199911339239410440017
   PubMed Web of Science ®Google Scholar
• AlexopoulosGSStreimJCarpenterDDochertyJPUsing antipsychotic agents in older patientsJ Clin Psychiatry200465Suppl 259914994733
   PubMed Web of Science ®Google Scholar
• AshcroftDMFrischerMLockettJChapmanSRVariations in prescribing atypical antipsychotic drugs in primary care: cross-sectional studyPharmacoepidemiol Drug Saf200211428528912138596
   PubMed Web of Science ®Google Scholar
• BarakYShamirEWeizmanRWould a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative studyJ Clin Psychopharmacol200222211512011910255
   PubMed Web of Science ®Google Scholar
• MeltzerHYThe role of serotonin in antipsychotic drug actionNeuropsychopharmacology199921Suppl 2106S115S10432496
   PubMed Web of Science ®Google Scholar
• ShinJYChoiNKJungSYLeeJKwonJSParkBJRisk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover studyJ Psychopharmacol201327763864423535349
   PubMed Web of Science ®Google Scholar
• RayWAChungCPMurrayKTHallKSteinCMAtypical antipsychotic drugs and the risk of sudden cardiac deathN Engl J Med2009360322523519144938
   PubMed Web of Science ®Google Scholar
• WetzelHWiesnerJHiemkeCBenkertOAcute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteersJ Psychiatr Res19942854614737897617
   PubMed Web of Science ®Google Scholar
• XiberasXMartinotJLMalletLIn vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophreniaJ Clin Psychopharmacol200121220721411270918
   PubMed Web of Science ®Google Scholar
• GareriPDe FazioPStiloMFerreriGDe SarroGConventional and atypical antipsychotics in the elderly: a reviewClin Drug Investig2003235287322
   Web of Science ®Google Scholar
• SchoemakerHClaustreYFageDNeurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivityJ Pharmacol Exp Ther1997280183978996185
   PubMed Web of Science ®Google Scholar
• AbbasAIHedlundPBHuangXPTranTBMeltzerHYRothBLAmisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivoPsychopharmacology (Berl)2009205111912819337725
   PubMed Web of Science ®Google Scholar
• SeemanPAtypical antipsychotics: mechanism of actionCan J Psychiatry2002471273811873706
   PubMed Web of Science ®Google Scholar
• StahlSMAntipsychotic polypharmacy, part 1: therapeutic option or dirty little secret?J Clin Psychiatry199960742542610453794
   PubMed Web of Science ®Google Scholar
• GareriPDe FazioPRussoEMariglianoNDe FazioSDe SarroGThe safety of clozapine in the elderlyExpert Opin Drug Saf20087552553818759705
   PubMed Web of Science ®Google Scholar
• KhanAJPreskornSHExamining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoringJ Psychiatr Pract200511528930116184070
   PubMedGoogle Scholar
• DeberdtWDyskenMWRappaportSAComparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementiaAm J Geriatr Psychiatry200513872273016085789
   PubMed Web of Science ®Google Scholar
• BurkeADTariotPNAtypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomesExpert Opin Pharmacother200910152407241419663744
   PubMed Web of Science ®Google Scholar
• JesteDVBlazerDCaseyDACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementiaNeuropsychopharmacology200833595797017637610
   PubMed Web of Science ®Google Scholar
• GreenBFocus on quetiapineCurr Med Res Opin199915314515110621920
   PubMed Web of Science ®Google Scholar
• KohenILesterPELamSAntipsychotic treatments for the elderly: efficacy and safety of aripiprazoleNeuropsychiatr Dis Treat20106475820361061
   PubMed Web of Science ®Google Scholar
• MarkowitzJSBrownCSMooreTRAtypical antipsychotics. Part I: pharmacology, pharmacokinetics, and efficacyAnn Pharmacother199933173859972387
   PubMed Web of Science ®Google Scholar
• BrookSLuceyJVGunnKPIntramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosisJ Clin Psychiatry2000611293394111206599
   PubMed Web of Science ®Google Scholar
• KechPEJrMcElroySLArnoldLMZiprasidone: a new atypical antipsychoticExpert Opin Pharmacother2001261033104211585006
   PubMedGoogle Scholar
• MadhusoodananSZaveriDPaliperidone use in the elderlyCurr Drug Saf20105214915220406162
   PubMedGoogle Scholar
• TauscherJKufferleBAsenbaumSTauscher-WisniewskiSKasperSStriatal dopamine-2 receptor occupancy as measured with (123 I) iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidolPsychopharmacology (Berl)20021621424912107616
   PubMed Web of Science ®Google Scholar
• ShahidMWalkerGBZornSHWongEHAsenapine: a novel psychopharmacologic agent with a unique human receptor signatureJ Psychopharmacol2009231657318308814
   PubMed Web of Science ®Google Scholar
• HermannRCYangDEttnerSLMarcusSCYoonCAbrahamMPrescription of antipsychotic drugs by office-based physicians in the United States, 1989–1997Psychiatr Serv200253442543011919355
   PubMed Web of Science ®Google Scholar
• JesteDVEasthamJHLohrJBTreatment of behavioral disorders and psychosisSalzmanCClinical Geriatric PsychopharmacologyBaltimore, MDWilliams and Wilkins1998106149
   Google Scholar
• TrifiroGSpinaEBrignoliOSessaECaputiAPMazzagliaGAntipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999–2002Eur J Clin Pharmacol2005611475315666172
   PubMed Web of Science ®Google Scholar
• CrismonLArgoTRBuckleyPFSchizophreniaDiPiroJTTalbertRLYeeGCMatzkeGRWellsBGPoseyMPharmacotherapy: A Pathophysiologic Approach7th edNew York, NYMcGraw-Hill200810991123
   Google Scholar
• SinghDO’ConnorDWEfficacy and safety of risperidone long-acting injection in elderly people with schizophreniaClin Interv Aging2009435135519750235
   PubMed Web of Science ®Google Scholar
• DavidsonMHarveyPDVervarckeJA long-term, multicenter, open-label study of risperidone in elderly patients with psychosisInt J Geriatr Psychiatry200015650651410861916
   PubMed Web of Science ®Google Scholar
• VigenCLMackWJKeefeRSCognitive effects of atypical antipsychotic medications in patients with Alzheimer’s disease: outcomes from CATIE-ADAm J Psychiatry2011168883183921572163
   PubMed Web of Science ®Google Scholar
• MadhusoodananSSinhaSBrennerRGuptaSBogunovicOUse of olanzapine for elderly patients with psychotic disorders: a reviewAnn Clin Psychiatry200113420121311958362
   PubMedGoogle Scholar
• SolomosKGeigerOOlanzapine use in the elderly: a retrospective analysisCan J Psychiatry200045215115510742874
   PubMed Web of Science ®Google Scholar
• MadhusoodananSBrennerRAlcantraAClinical experience with quetiapine in elderly patients with psychotic disordersJ Geriatr Psychiatry Neurol2000131283210753004
   PubMed Web of Science ®Google Scholar
• KamKYJalinAMChoiYWZiprasidone attenuates brain injury after focal cerebral ischemia induced by middle artery occlusion in ratsProg Neuropsychopharmacol Biol Psychiatry2012391697422627197
   PubMed Web of Science ®Google Scholar
• RadoJJanicakPGAripiprazole for late-life schizophreniaClin Interv Aging2010525325820852672
   PubMed Web of Science ®Google Scholar
• PigottTACarsonWHSaraARAripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week studyJ Clin Psychiatry20036491048105614628980
   PubMed Web of Science ®Google Scholar
• MadhusoodananSBrennerRGuptaSReddyHBogunovicOClinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studiesCNS Spectr200491186286715520608
   PubMed Web of Science ®Google Scholar
• TzimosASamokhvalovVKramerMSafety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with 6-month open label extensionAm J Geriatr Psychiatry2008161314318165460
   PubMed Web of Science ®Google Scholar
• JesteDVBlazerDCaseyDACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementiaNeuropsychopharmacol2008335957970
   PubMed Web of Science ®Google Scholar
• WoltersECBerendseHWManagement of psychosis in Parkinson’s diseaseCurr Opin Neurol200114449950411470967
   PubMed Web of Science ®Google Scholar
• TsanJYStockEMGonzalezJMMortality and guideline-concordant care for older patients with schizophrenia: a retrospective longitudinal studyBMC Med20121014723181341
   PubMed Web of Science ®Google Scholar
• FelmetKZisookSKasckowJWElderly patients with schizophrenia and depression: diagnosis and treatmentClin Schizophr Relat Psychoses20114423925021177241
   PubMedGoogle Scholar
• JesteDVMaglioneJETreating older adults with schizophrenia: challenges and opportunitiesSchizophr Bull201339596696823552180
   PubMed Web of Science ®Google Scholar
• KuehnBMQuestionable antipsychotic prescribing remains common, despite serious risksJAMA2010303161582158420424239
   PubMed Web of Science ®Google Scholar
• KatzRJesteDVMintzerJEClydeCNapolitanoJBrecherMComparison of risperidone and placebo for psychosis and behavioral disturbance associated with dementia: a randomized, double-blind trialJ Clin Psychiatry199960210711510084637
   PubMed Web of Science ®Google Scholar
• LavretskyHSultzerDA structured trial of risperidone for the treatment of agitation in dementiaAm J Geriatr Psychiatry1998621271359581208
   PubMed Web of Science ®Google Scholar
• GareriPMariglianoNMDe FazioSAntipsychotics and dementiaBMC Geriatr201010Suppl 1A93
   Google Scholar
• DoreyJMBeauchetOThomas AntérionCBehavioral and psychological symptoms of dementia and bipolar spectrum disorders: review of the evidence of a relationship and treatment implicationsCNS Spectr200813979680318849899
   PubMed Web of Science ®Google Scholar
• MaherARTheodoreGSummary of the comparative effectiveness review on off-label use of atypical antipsychoticsJ Manag Care Pharm2012185 Suppl BS1S2022784311
   PubMedGoogle Scholar
• BallardCGGauthierSCummingsJLManagement of agitation and aggression associated with Alzheimer diseaseNat Rev Neurol20095524525519488082
   PubMed Web of Science ®Google Scholar
• PellandCTrudelJFAtypical antipsychotic efficacy and safety in managing delirium: a systematic review and critical analysisPsychol Neuropsychiatr Vieil200972109119 French19473954
   PubMedGoogle Scholar
• MeyersBSFlintAJRothschildAHA double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)Arch Gen Psychiatry200966883884719652123
   PubMed Web of Science ®Google Scholar
• AlexopoulosGSPharmacotherapy for late-life depressionJ Clin Psychiatry2011721e0421272511
   PubMedGoogle Scholar
• BermanRMFavaMThaseMEAripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressantsCNS Spectr200914419720619407731
   PubMed Web of Science ®Google Scholar
• SajatovicMCoconceaNIgnacioRVAripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trialJ Clin Psychiatry2008691414618312036
   PubMed Web of Science ®Google Scholar
• SajatovicMCalabreseJRMullenJQuetiapine for the treatment of bipolar mania in older adultsBipolar Disord200810666267118837860
   PubMed Web of Science ®Google Scholar
• VasudevAThomasA“Bipolar disorder” in the elderly: what’s in a name?Maturitas201066323123520307944
   PubMed Web of Science ®Google Scholar
• AzizRLorbergBTampiRRTreatments for late-life bipolar disorderAm J Geriatr Pharmacother20064434736417296540
   PubMedGoogle Scholar
• NewcomerJSecond-generation (atypical) antipsychotic and metabolic effects: a comprehensive literature reviewCNS Drugs200519Suppl 119315998156
   PubMed Web of Science ®Google Scholar
• ParienteAFourrier-ReglatADucruetTAntipsychotic use and myocardial infarction in older patients with treated dementiaArch Intern Med2012172864865322450214
   PubMedGoogle Scholar
• GillSSRochonPAHerrmannNA typical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort studyBMJ200533044515668211
   PubMed Web of Science ®Google Scholar
• Citizens Commission on Human RightsUS Food and Drug Administration Warning on Antipsychotic DrugsCaliforniaCitizens Commission on Human Rights2005 Available from: http://www.cchrint.org/pdfs/US_Food_and_Drug_Administration_Warnings_on_Antipsychotic_Drugs.pdfAccessed August 05, 2014
   Google Scholar
• FDA requests boxed warnings on older class of antipsychotic drugs news releaseSilver Spring, MDUS Food and Drug Administration2008 [updated June 16, 2008; cited June 24, 2008] Available from: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116912.htmAccessed July 31, 2014
   Google Scholar
• LiperotiROnderGLandiFAll-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort studyJ Clin Psychiatry200970101340134719906339
   PubMed Web of Science ®Google Scholar
• TrifiroGGambassiGSenEFAssociation of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case–control studyAnn Intern Med2010152741842520368647
   PubMed Web of Science ®Google Scholar
• LiperotiRPedoneCLapaneKLMorVBernabeiRGambassiGVenous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agentsArch Intern Med2005165222677268216344428
   PubMedGoogle Scholar
• KleijerBCHeerdinkEREgbertsTCJansenPAvan MarumRJAntipsychotic drug use and the risk of venous thromboembolism in elderly patientsJ Clin Psychopharmacol201030552653020814323
   PubMed Web of Science ®Google Scholar
• ZarebaWLinDAAntipsychotic drugs and QT interval prolongationPsychiatr Q200374329130612918603
   PubMed Web of Science ®Google Scholar
• GlassmanAHBiggerJTJrAntipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden deathAm J Psychiatry2001158111774178211691681
   PubMed Web of Science ®Google Scholar
• ChungAKChuaSEEffects on prolongation of Bazett’s corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysisJ Psychopharmacol201125564666620826552
   PubMed Web of Science ®Google Scholar
• GareriPDe FazioPManfrediVGDe SarroGUse and safety of antipsychotics in behavioral disorders in elderly demented peopleJ Clin Psychopharmacol201434110912324158020
   PubMed Web of Science ®Google Scholar
• RettenbacherMAHoferAKemmlerGFleischhackerWWNeutropenia induced by second generation antipsychotics: a prospective investigationPharmacopsychiatry2010432414420175050
   PubMed Web of Science ®Google Scholar
• LiXCameronMDPotential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosisChem Res Toxicol20122551004101122506851
   PubMed Web of Science ®Google Scholar
• BaruchYTadgerSPlopskiIBarakYAsenapine for elderly bipolar manic patientsJ Affect Disord2013145113013222877962
   PubMed Web of Science ®Google Scholar
• CorrellCUFrom receptor pharmacology to improved outcomes: individualizing the selection, dosing, and switching of antipsychoticsEur Psychiatry201025Suppl 2S12S2120620881
   PubMed Web of Science ®Google Scholar
• OndoWGTintnerRVoungKDLaiDRingholzGDouble-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson’s diseaseMov Disord200520895896315800937
   PubMed Web of Science ®Google Scholar
• PepersackTGillesCPetrovicMPrevalence of orthostatic hypotension and relationship with drug use amongst older patientsActa Clin Belg201368210711223967718
   PubMed Web of Science ®Google Scholar
• ShulmanMJennifer NjokuIManuPThrombotic complications of treatment with antipsychotic drugsMinerva Med2013104217518423514994
   PubMed Web of Science ®Google Scholar